Anika Therapeutics (ANIK) Total Debt (2010 - 2022)

Anika Therapeutics (ANIK) has 7 years of Total Debt data on file, last reported at $4.3 million in Q2 2022.

• On a quarterly basis, Total Debt fell 74.42% year-over-year to $4.3 million in Q2 2022; TTM through Jun 2022 was $4.3 million, a 74.42% decrease from a year earlier, with the FY2021 full-year figure at $4.3 million, down 67.04% from the prior year.
• Total Debt for Q2 2022 stood at $4.3 million, roughly flat from $4.3 million in the prior quarter.
• Over the last five years, Total Debt for ANIK reached as high as $50.0 million in Q2 2020 and fell as low as $4.3 million in Q3 2021.
• Historically, Total Debt has averaged $16.3 million across 3 years, with a median of $13.1 million in 2020.
• On a YoY basis, Total Debt climbed as much as 66.26% in 2021 and fell as far as 82.8% in 2021.
• Year by year, Total Debt stood at $13.1 million in 2020, then slumped by 67.04% to $4.3 million in 2021, then changed by 0.0% to $4.3 million in 2022.
• Per Business Quant data, the three most recent Total Debt figures were $4.3 million in Q2 2022, $4.3 million in Q1 2022, and $4.3 million in Q4 2021.